Q1 2024 update: M&A activity in pharmaceutical in Sweden
In the Swedish pharmaceutical industry, there were 6 M&A deals announced in Q1 2024, worth a total value of $2.3m,…
In the Swedish pharmaceutical industry, there were 6 M&A deals announced in Q1 2024, worth a total value of $2.3m,…
Analysis of the key themes driving M&A activity reveals that personalization accounted for 2 pharmaceutical deals announced in Q1 2024,…
Analysis of the key themes driving M&A activity reveals that individualism & expression accounted for 2 pharmaceutical deals announced in…
Analysis of the key themes driving M&A activity reveals that immuno-oncology accounted for 16 pharmaceutical deals announced in Q1 2024,…
Analysis of the key themes driving M&A activity reveals that energy transition accounted for 3 pharmaceutical deals announced in Q4…
Analysis of the key themes driving M&A activity reveals that cloud accounted for 3 pharmaceutical deals announced in Q4 2023,…
Analysis of the key themes driving M&A activity reveals that renewable energy accounted for 2 pharmaceutical deals announced in Q4…
Analysis of the key themes driving M&A activity reveals that easy & affordable accounted for 3 pharmaceutical deals announced in…
Analysis of the key themes driving M&A activity reveals that remote patient monitoring accounted for 3 pharmaceutical deals announced in…
Analysis of the key themes driving M&A activity reveals that electronic medical record (emr) systems accounted for 2 pharmaceutical deals…